disufenton sodium has been researched along with Cerebral Infarction in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, M; He, QP; Li, PA; Siesjö, BK; Yong, G | 1 |
| Savitz, SI | 1 |
| Alderfer, V; Ashwood, T; Davalos, A; Davis, SM; Diener, HC; Grotta, J; Hårdemark, HG; Lees, KR; Lyden, P; Rodichok, L; Shuaib, A; Wasiewski, W | 1 |
| Buchan, AM; Cheng, M; Ma, JY; Maples, KR; Zhao, Z | 1 |
| Borelli, AR; Cross, AJ; Green, AR; Sydserff, SG | 1 |
1 review(s) available for disufenton sodium and Cerebral Infarction
| Article | Year |
|---|---|
A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke.
Topics: Animals; Benzenesulfonates; Cerebral Infarction; Clinical Trials as Topic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Intracranial Embolism; Neuroprotective Agents; Reproducibility of Results; Research Design; Stroke | 2007 |
1 trial(s) available for disufenton sodium and Cerebral Infarction
| Article | Year |
|---|---|
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
Topics: Age Factors; Aged; Antioxidants; Benzenesulfonates; Brain; Brain Ischemia; Cerebral Hemorrhage; Cerebral Infarction; Comorbidity; Double-Blind Method; Drug Administration Schedule; Emergency Medical Services; Encephalitis; Female; Humans; Hyperglycemia; Injections, Intravenous; Male; Meta-Analysis as Topic; Middle Aged; Neuroprotective Agents; Placebos; Prognosis; Stroke; Treatment Failure | 2008 |
3 other study(ies) available for disufenton sodium and Cerebral Infarction
| Article | Year |
|---|---|
NXY-059, a nitrone with free radical trapping properties inhibits release of cytochrome c after focal cerebral ischemia.
Topics: Animals; Benzenesulfonates; Cell Death; Cerebral Infarction; Cytochromes c; Free Radical Scavengers; Ischemic Attack, Transient; Male; Mitochondria; Nitrogen Oxides; Rats; Rats, Wistar; Reperfusion | 2003 |
NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
Topics: Animals; Benzenesulfonates; Blood Pressure; Brain Ischemia; Cerebral Cortex; Cerebral Infarction; Cerebrovascular Circulation; Free Radical Scavengers; Free Radicals; Immunohistochemistry; Male; Microtubule-Associated Proteins; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitrogen Oxides; Rats; Rats, Inbred SHR | 2001 |
Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
Topics: Administration, Cutaneous; Animals; Benzenesulfonates; Brain Ischemia; Cerebral Cortex; Cerebral Infarction; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Infusion Pumps, Implantable; Ischemic Attack, Transient; Male; Neuroprotective Agents; Nitrogen Oxides; Rats; Rats, Inbred WKY | 2002 |